Innovation

AMSbiopharma participates in various research and development projects, our own or in collaboration with other private or public entities at regional, national or international level, always aimed at offering new analytical solutions that favour scientific progress and the continuous improvement of processes in different sectors.

Bioentonomy: New bioeconomy strategies through insect biotechnology

The Center for the Development of Industrial Technology (CDTI) has granted AMSbiopharma and Alfredo Iñesta funding for the development of the “Bioentonomy” research project.

Companies: AMSbiopharma and Alfredo Iñesta.

Objectives: Development and formation of new products for use as agricultural inputs from the valorization of insects fed with agro-industrial waste.
Study of the protein and lipid fraction from insect biomass showing interesting biological activity.

Total budget: 642.774 €

This project is part of the call for R&D projects, subsidized by the CDTI, supported by the Ministry of Science, Innovation and Universities and co-financed with European Union Structural Funds (ERDF) within the “Smart Growth Operational Program 2014-2020”.

IGAPE Grants for Business Investment Projects

Business investment AMSbiopharma. Expansion of the capacity of an existing facility (IG253.2019.1.62).

Objective: We seek to increase our portfolio of services for the pharmaceutical sector and for this it is essential to acquire the latest technology equipment to meet the needs of this sector. Due to the requirements in the pharmacopoeia sector, all the equipment must be of exclusive use, which forces us to equip ourselves with new equipment, high technology equipment that will allow us to meet the needs of our customers.

This company was the beneficiary of a grant from IGAPE’s business investment program, which aims to foster the balanced development of the Galician territory and promote the growth and consolidation of SMEs.

Operation co-financed by the European Union.

Galicia ERDF Operational Program 2014-2020.

Achieving a more competitive business fabric.
A way of making Europe.

IGAPE grants for Industry 4.0 Digitalization

AMSbiopharma’s digitalization process (IG240.2019.1.54)

Objective: Implementation of Part 11 CRF 21 certification.

Results: It allows us the secularized traceability of the processes of primary data generation, acquisition, processing, reporting, encryption and archiving of digital data obtained with the Sciex 5500 equipment in its application in studies in GLP environment.

This company was the beneficiary of a grant from IGAPE’s “Industry 4.0 digitalization” program, which aims to promote the digital transformation of the company and favor the growth and consolidation of SMEs, improving their financing, technology and access to advanced support services.

Operation co-financed by the European Union.

Galicia ERDF Operational Program 2014-2020.

Achieving a more competitive business fabric.
A way of making Europe.

Talento Sénior Program

Staff co-funded by the Xunta de Galicia outside the Resolution of the Axencia Galega de Innovación of May 29, 2019.
04_IN858A_2019_1642437